[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335009-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335009-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ubiquitin-specific-proteases-usps-in-leukemia-a-systematic-review","Ubiquitin-specific proteases (USPs) in leukemia - a systematic review","","Leukemia, a major blood cancer defined by affected white blood cell type and disease tempo, requires improved mechanistic insight to support new therapies. Ubiquitin-specific proteases (USPs), a group of deubiquitinating enzymes, regulate tumor-suppressive and oncogenic pathways, yet a unified view of their roles remains incomplete. This systematic review synthesizes evidence on how USPs contribute to pathogenesis across leukemia types and outlines implications for diagnosis, prognosis, and treatment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ubiquitin-specific-proteases-usps-in-leukemia-a-systematic-review/335009/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ubiquitin-specific-proteases-usps-in-leukemia-a-systematic-review/335009.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the focus of this systematic review?","Question",{"text":63,"@type":64},"It examines how ubiquitin-specific proteases (USPs) contribute to the pathogenesis of different leukemia types.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which databases were searched in the methods section?",{"text":68,"@type":64},"The review searched MEDLINE (via PubMed), Scopus, and Web of Science using PRISMA guidelines.",{"name":70,"@type":61,"acceptedAnswer":71},"What outcomes does the review associate with USP activity in leukemia?",{"text":72,"@type":64},"USP activity is linked to chromosomal aberrations, proliferation, differentiation, apoptosis, cell-cycle control, DNA repair, and drug resistance, affecting leukemia progression and chemotherapy sensitivity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335009,1791101447,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":4},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Zangooie etal. BMC Cancer (2024) 24:894 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-12614-x](https://doi.org/10.1186/s12885-024-12614-x)  \nSYSTEMATIC REVIEW Open Access  \nUbiquitin-specific proteases (USPs) in leukemia: a systematic review  \nAlireza Zangooie 1,2†, ShimaTavoosi3†, Mahan Arabhosseini4, Aram Halimi5,6, Helia Zangooie7,  \nAmir Hossein Baghsheikhi8, Soheila Rahgozar3, Mohammad Ahmadvand9, Alireza Mosavi Jarrahi 10* and Zahra Salehi 11*  \nAbstract  \nBackground Leukemia, a type of blood cell cancer, is categorized by the type of white blood cells affected (lymphocytes or myeloid cells) and disease progression (acute or chronic) . In 2020, it ranked 15th among the  \nmost diagnosed cancers and 11th in cancer-related deaths globally, with 474,519 new cases and 311,594 deaths (GLOBOCAN2020) . Research into leukemia’s development mechanisms may lead to new treatments. Ubiquitinspecific proteases (USPs), a family of deubiquitinating enzymes, play critical roles in various biological processes, with both tumor-suppressive and oncogenic functions, though a comprehensive understanding is still needed.  \nAim This systematic review aimed to provide a comprehensive review of how Ubiquitin-specific proteases are involved in pathogenesis of different types of leukemia.  \nMethods We systematically searched the MEDLINE (via PubMed), Scopus, and Web of Science databases according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA) to identify relevant studies focusing on the role of USPs in leukemia. Data from selected articles were extracted, synthesized, and organized to present a coherent overview of the subject matter.  \nResults The review highlights the crucial roles of USPs in chromosomal aberrations, cell proliferation, differentiation, apoptosis, cell cycle regulation, DNA repair, and drug resistance. USP activity significantly impacts leukemia progression, inhibition, and chemotherapy sensitivity, suggesting personalized diagnostic and therapeutic approaches. Ubiquitin-specific proteases also regulate gene expression, protein stability, complex formation, histone deubiquitination, and protein repositioning in specific leukemia cell types.  \nConclusion The diagnostic, prognostic, and therapeutic implications associated with ubiquitin-specific proteases (USPs) hold significant promise and the potential to transform leukemia management, ultimately improving patient outcomes.  \n†Alireza Zangooie and ShimaTavoosi contributed equally to this work and share first authorship.  \n*Correspondence:  \nAlireza Mosavi Jarrahi[rmosavi@yahoo.com](rmosavi@yahoo.com)  \nZahra Salehi [zahra.salehi6463@yahoo.com](zahra.salehi6463@yahoo.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024, corrected publication 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons](http://creativecommons). org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nZangooie et al.","cbCaisfnenBu0uSR","https://ap.wps.com/l/cbCaisfnenBu0uSR","pdf",5586250,16,"English","# Abstract\n## Background\n## Aim\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the focus of this systematic review?\",\"answer\":\"It examines how ubiquitin-specific proteases (USPs) contribute to the pathogenesis of different leukemia types.\"},{\"question\":\"Which databases were searched in the methods section?\",\"answer\":\"The review searched MEDLINE (via PubMed), Scopus, and Web of Science using PRISMA guidelines.\"},{\"question\":\"What outcomes does the review associate with USP activity in leukemia?\",\"answer\":\"USP activity is linked to chromosomal aberrations, proliferation, differentiation, apoptosis, cell-cycle control, DNA repair, and drug resistance, affecting leukemia progression and chemotherapy sensitivity.\"}]","Ubiquitin-specific proteases (USPs) in leukemia - a systematic review | PDF",1790009215]